Compositions
US8841264B2 · kind B2 · utility
21Cited by
12References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2007 |
| Grant date | Sep 23, 2014 |
| Priority date | — |
| Expiry date | Aug 14, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions containing a combination of hydroxytyrosol and resveratrol or liqustilide or (−)-epigallocatechin gallate or honokiol or genistein or Magnolia bark extract or a combination of oleuropein and resveratrol or ligustilide are used to treat inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.